Company: QXO-PB
Filing Date: 2025-05-29
Form Type: 424B7
Source: 0001104659-25-054254
Chunk: 17

Company: QXO, Inc.
Filing Date: 2025-05-29
Form: 424B7
Chunk 17
---
;

•

approximately 32,782,774 additional shares of common stock that were available for issuance under the Plan as of May 15, 2025;

•

219,010,074 shares of common stock issuable upon conversion of shares of our Convertible Perpetual Preferred Stock outstanding as of May 15, 2025;

•

219,010,074 shares of common stock issuable upon the exercise of our warrants outstanding as of May 15, 2025, at a weighted-average exercise price of $7.42 per share;

•

42,000,000 shares of common stock issuable upon the exercise of our pre-funded warrants outstanding as of May 15, 2025, at a weighted-average exercise price of $0.00001 per share;

•

any shares of common stock underlying our outstanding Depositary Shares; and

•

any shares of common stock that may be paid in respect of dividends on the outstanding Depositary Shares.

Unless otherwise indicated, all information in this prospectus supplement assumes no exercise of outstanding options or warrants or vesting of outstanding RSUs or PSUs after May 15, 2025.

<div align='center'>S-7</div>

TABLE OF CONTENTS

Summary Historical and Unaudited Pro Forma Financial Information of QXO The following table presents summary historical consolidated financial information for QXO and unaudited pro forma combined financial information for QXO and QXO Building Products as of the dates and for the periods indicated. The summary historical consolidated statements of operations data for the years ended December 31, 2024 and 2023 and the consolidated balance sheet data as of December 31, 2024 and 2023 presented below have been derived from QXO’s audited consolidated financial statements incorporated by reference into this prospectus supplement. In addition, the summary historical consolidated statements of operations data for the three months ended March 31, 2025 and 2024 and the consolidated balance sheet data as of as of March 31, 2025 have been derived from QXO’s unaudited condensed financial statements incorporated by reference into this prospectus supplement. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited financial statements and reflect, in the opinion of management, adjustments of a normal, recurring nature that are necessary for a fair statement of the unaudited condensed consolidated financial statements. The information set forth below should be read together with the other information contained in QXO’s Annual Report